Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by jawcellison Jul 23, 2015 10:00pm

188 Views

Post# 23955089

RE:Roche Says Drug Meets Bladder Cancer Target

sigma aldrich, the producer of TLT's TD1433, was bought out by Merck :)

as a side bar a tiny company in Halifax, Immunovaccine - IMV - has just recieved FDA fast track appoval for its vaccine to destroy ovrian cancer.

Bullboard Posts

Debt-free cannabis company set for next stage of growth